Back to Results

Nu Skin Enterprises Inc (NUS)

Featured in High-Beta Stocks

Nu Skin Enterprises, Inc. is a consumer staples company focused on beauty and wellness products. Through its subsidiaries, the company develops and distributes skin care, cosmetics, nutritional supplements, and related personal care items worldwide. Its product lineup includes devices and brands such as ageLOC LumiSpa, ageLOC LumiSpa iO, Nu Skin RenuSpa iO, ageLOC TruFace, Prysm iO, Nutricentials, Beauty Focus, ageLOC TRME, and LifePak. Nu Skin sells under the Nu Skin, Pharmanex, and ageLOC names through retail stores, websites, digital channels, independent direct sellers and marketers, and service centers. The company also conducts research and product development in skin care, nutritional supplements, and devices. Founded in 1984, Nu Skin is headquartered in Provo, Utah, and operates across Mainland China, South Korea, Southeast Asia/Pacific, the Americas, Japan, Hong Kong/Taiwan, and Europe & Africa.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NYSE-NUS
$8.93
69.1% Upside
Bargain
—
—
—
Good
—
—
0.24
4.5%
August 5, 2026
4.7x
0.3x
0.2x
258.8 M
357.2 M
54.0%
97.1%
4.0
21.5%
76.2%
Valuation • Fair Value

Nu Skin Enterprises Inc (NYSE-NUS) Fair Value by Valuation Model

Compare the primary fair value estimate for Nu Skin Enterprises Inc (NYSE-NUS) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$8.93

Estimated upside of 69.1% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

NM

Discounted cash flow valuation reference.

Ben Graham Formula Value

$12.46

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

NM

Earnings power value estimate.

Comps Fair Value

$8.93

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for Nu Skin Enterprises Inc (NYSE-NUS) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Nu Skin Enterprises Inc (NYSE-NUS)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

1.441 B

Current operating scale indicator.

Revenue Forecast

1.425 B

Forward revenue estimate.

EBITDA

131.9 M

Current operating profitability reference.

EBITDA Forecast

162.9 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Nu Skin Enterprises Inc (NYSE-NUS) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Nu Skin Enterprises Inc (NYSE-NUS)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Good

Positive financial-health read.

Piotroski Score

7

Relatively strong quality score.

Beneish M-Score

-2.70

No elevated caution signal from this screen.

Altman Z-Score

4.0

Relatively strong balance-sheet zone.

FCF / Net Income

76.2%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Nu Skin Enterprises Inc (NYSE-NUS). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Nu Skin Enterprises Inc (NYSE-NUS)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

August 5, 2026

Days to Earnings

15

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

4.5%

Income yield reference.

Upcoming Dividend

0.24

Upcoming distribution amount.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

USD

Currency used for the distribution.

Payout Ratio

21.5%

Dividend payout reference.

How to read events and dividends

This section helps investors track time-sensitive items for Nu Skin Enterprises Inc (NYSE-NUS), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Nu Skin Enterprises Inc (NYSE-NUS) Stock Forecast & Technical Outlook

Review Nu Skin Enterprises Inc (NYSE-NUS) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Neutral

The 15-minute technical read for Nu Skin Enterprises Inc (NYSE-NUS) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Neutral

The 1-hour technical read for Nu Skin Enterprises Inc (NYSE-NUS) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Neutral

The daily technical read for Nu Skin Enterprises Inc (NYSE-NUS) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Nu Skin Enterprises Inc (NYSE-NUS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Nu Skin Enterprises Inc (NYSE-NUS) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Nu Skin Enterprises Inc (NYSE-NUS)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Not available

Analyst recommendation data for Nu Skin Enterprises Inc (NYSE-NUS) is not currently available.

Buy 0
Hold 0
Sell 0
FAQ • Fast Investor Answers

Nu Skin Enterprises Inc (NYSE-NUS) Stock FAQ

Quick answers about Nu Skin Enterprises Inc (NYSE-NUS) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$8.93
Estimated upside 69.1%
Valuation Rating
Undervalued
Estimated upside of 69.1%
Analyst Target
Not available
Data is currently unavailable
Financial Health
Good
Current financial-health read

The current fair value estimate for Nu Skin Enterprises Inc (NYSE-NUS) is $8.93. This implies an estimated upside of 69.1% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 69.1% versus the current market price.

An analyst price target for Nu Skin Enterprises Inc (NYSE-NUS) is not currently available in the latest data file.

The current financial health read for Nu Skin Enterprises Inc (NYSE-NUS) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Nu Skin Enterprises Inc (NYSE-NUS) is August 5, 2026.

Based on the current data, dividend yield is 4.5%, upcoming dividend amount is 0.24.

The current P/E ratio listed for Nu Skin Enterprises Inc (NYSE-NUS) is 4.7x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Nu Skin Enterprises Inc is 258.8 M.

The current enterprise value listed for Nu Skin Enterprises Inc is 357.2 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Nu Skin Enterprises Inc is NYSE-NUS, and the stock is listed on NYSE.

Nu Skin Enterprises Inc (NYSE-NUS) is listed on NYSE.

The current debt-to-total-capital ratio listed for Nu Skin Enterprises Inc is 54.0%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Nu Skin Enterprises Inc is 97.1%. Free float helps investors understand how much of the share base is available for public trading.

Similar Personal Care Products Stocks on NYSE View more

Unilever PLC ADR (UL) Unilever PLC ADR (UL)
Kenvue Inc (KVUE) Kenvue Inc (KVUE)
Estee Lauder Companies Inc (EL) Estee Lauder Companies Inc (EL)
ELF Beauty Inc (ELF) ELF Beauty Inc (ELF)
Coty Inc (COTY) Coty Inc (COTY)
Bellring Brands LLC (BRBR) Bellring Brands LLC (BRBR)
Edgewell Personal Care Co (EPC) Edgewell Personal Care Co (EPC)
Herbalife Nutrition Ltd (HLF) Herbalife Nutrition Ltd (HLF)
USANA Health Sciences Inc (USNA) USANA Health Sciences Inc (USNA)
Yatsen Holding (YSG) Yatsen Holding (YSG)
MEDIFAST INC (MED) MEDIFAST INC (MED)
AXIL Brands Inc (AXIL) AXIL Brands Inc (AXIL)